STRS Ohio’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,355
Closed -$970K 2336
2025
Q1
$970K Sell
7,355
-5,355
-42% -$667K ﹤0.01% 885
2024
Q4
$1.06M Sell
12,710
-4,089
-24% -$336K ﹤0.01% 834
2024
Q3
$1.23M Buy
16,799
+846
+5% +$63.6K ﹤0.01% 834
2024
Q2
$1.09M Sell
15,953
-7,847
-33% -$544K ﹤0.01% 843
2024
Q1
$1.65M Sell
23,800
-2,500
-10% -$172K 0.01% 718
2023
Q4
$1.88M Sell
26,300
-1,600
-6% -$92K 0.01% 634
2023
Q3
$1.45M Buy
27,900
+900
+3% +$52.4K 0.01% 740
2023
Q2
$1.71M Buy
27,000
+6,300
+30% +$393K 0.01% 688
2023
Q1
$1.12M Sell
20,700
-900
-4% -$43.5K ﹤0.01% 888
2022
Q4
$1.14M Sell
21,600
-9,300
-30% -$466K 0.01% 884
2022
Q3
$1.44M Hold
30,900
0.01% 711
2022
Q2
$1.76M Buy
30,900
+18,000
+140% +$1.02M 0.01% 649
2022
Q1
$789K Buy
12,900
+4,600
+55% +$239K ﹤0.01% 1186
2021
Q4
$434K Buy
8,300
+900
+12% +$37.8K ﹤0.01% 1524
2021
Q3
$275K Hold
7,400
﹤0.01% 1688
2021
Q2
$302K Buy
+7,400
New +$274K ﹤0.01% 1717
2020
Q4
Sell
-2,900
Closed -$74K 2300
2020
Q3
$74K Sell
2,900
-2,000
-41% -$45.6K ﹤0.01% 1904
2020
Q2
$125K Buy
+4,900
New +$99.2K ﹤0.01% 1746
2014
Q4
Sell
-2,370
Closed -$32K 1817
2014
Q3
$32K Buy
+2,370
New +$35.6K ﹤0.01% 1699

Other funds holding ITCI